TABLE 1.
Singletons | ||||
---|---|---|---|---|
Variable | Combined | Peru | Rochester | Multiples |
Maternal, n | 68 | 43 | 20 | N = 5 |
Age, y | 22.73 ± 5.00 | 23.26 ± 4.38a | 19.55 ± 3.87b | 31.0 ± 2.34c |
BMI2 | 28.95 ± 5.64 | 26.48 ± 2.66b | 32.52 ± 6.67a | 35.64 ± 7.74a |
Neonatal, n | 74 | 42 | 19 | 11 |
GA, wk | 38.63 ± 0.05 | 39.75 ± 1.00a | 39.52 ± 1.60a | 33.81 ± 2.52b |
PTB, % | 20 | 03a | 16a | 82b |
Birth weight, g | 2970.96 ± 587.91 | 3104.14 ± 417.56a | 3169.74 ± 548.25a | 2107.00 ± 492.79b |
LBW, % | 21 | 05a | 21b | 82c |
SGA, % | 26 | 37a | 21b | 0c |
Male, % | 52 | 44 | 68 | 45 |
Values are means ± SDs unless otherwise indicated. Data were analyzed by Wilcoxon rank sum test, ANOVA, or chi-square test. Different superscript letters indicate significant differences between cohorts. GA, gestational age; LBW, low birth weight; PTB, preterm birth; SGA, small for gestational age.
The BMI value obtained during the third trimester when dosing occured.